NCT01909934 2025-09-19
Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
Takeda
Phase 4 Completed
Takeda
Takeda
Phoenix Children's Hospital
Celgene
Children's Hospital of Michigan
Universitaire Ziekenhuizen KU Leuven